A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy.

ABSTRACT:

Background

Hepatic fibrosis is a health challenge due to the absence of satisfactory therapy, especially at the cirrhosis stage. Dahuang Zhechong pill (DHZCP)-based therapy is reportedly a successful treatment for hepatic fibrosis and is even beneficial for the treatment of cirrhosis. Hence, a systematic review and clinical evidence assessment of DHZCP-based therapy should be performed, and clinical recommendations based on its efficacy for the treatment of hepatic fibrosis should be generated. With respect to potential indicators, the comparative value of the hepatic function, spleen thickness, and portal vein internal diameter should be evaluated.

Materials and methods

PubMed, the Excerpta Medica Database, the Cochrane Library, the Web of Science, the WanFang Database, the

SUBMITTER: Ye Z 

PROVIDER: S-EPMC9616118 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature